Can detection and prediction models for Alzheimer’s Disease be applied to Prodromal Parkinson’s Disease using explainable artificial intelligence?

At Altoida, we use digital biomarkers to radically change the method of assessing brain health and cognitive diseases. After nearly two decades of research, we are developing a platform and device to measure and analyze cognitive biomarkers associated with cognitive impairment to evaluate perceptual and memory function.